COVID-19 hits ARV Supply

Description

By Faith Chapfika
Critical Antiretroviral drug supplies to the country have been affected by Covid 19 pandemic raising fears that a shortage could affect thousands who are on treatment.
Ministry of Health, deputy director, Tsitsi Apollo in an interview on the sidelines of the World‘s Aids day commemorations said the government had taken measures to avert the shortages.
‘’You are aware of the Covid-19 pandemic and the restrictions in terms of movement of goods and services so they have been some delays in receiving shipments of some of some Arv’s from the manufacturers overseas,’’ said Apollo.
She said notwithstanding the delays, the government has a stop-gap measure which will see those on Art receiving ARV’s supply for just three months instead of the normal six months’ supply.
“The slight delays may affect the availability of ARV’S, however, people living with HIV should be able to receive three months supplies of ARV’S because previously they have were allowed to get longer reviews of up to six months but because of those delays in shipments they are reducing that to three months so that everyone who living with HIV is at least able to access some medicine,” she said.
Acting minister of Health, Amon Murwira, also assured the nation saying ARV’s remained on the priority list of government and would not run short.
“Some fear that government will divert resources meant for HIV and AIDS response to Covid 19, that will not happen and therefore there will be no shortages,” Murwira said.